http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34003395

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 955
issn 1436-3291
1436-3305
issueIdentifier 5
pageRange 943-955
publicationName Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
startingPage 943
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6a9a2fbcb13be69328eda14f37a3687b
bibliographicCitation Lu Z, Yang S, Luo X, Shi Y, Lee J, Deva S, Liu T, Chao Y, Zhang Y, Huang R, Xu Y, Shen Z, Shen L. The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinoma. Gastric Cancer. 2022 Jul 02;25(5):943–55. doi: 10.1007/s10120-022-01308-7.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7d561b0aa1ccdcbba274be336c30389
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec5e76905a888bc358415a09a35ab187
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad6d3d11a789905b0f5700ac48ca8fee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2af5ae69576bee295811375232421053
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f061d2751c62799c834b3c5f7708d98
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ffc8b504e95bda7f12c2fa7617055f0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55b64d0e8367565774e2e67ed66e40a9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98860429d07c57113207101a05ce8b7b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1dc8b46e9d6b20fbe52c2e66c38e14a8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c1bf2f47030c11faa565a60d90ea86c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df206e6443cc9eba40e4f6b17178b58b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5fd88e19385e7a4d7e9c320fa4c2245d
date 2022-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1007/s10120-022-01308-7
https://pubmed.ncbi.nlm.nih.gov/35778636
https://pubmed.ncbi.nlm.nih.gov/PMC9365737
isPartOf https://portal.issn.org/resource/ISSN/1436-3291
https://portal.issn.org/resource/ISSN/1436-3305
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/26774
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinoma
discusses http://id.nlm.nih.gov/mesh/C562730
http://id.nlm.nih.gov/mesh/M0555734
http://id.nlm.nih.gov/mesh/M000734928
http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M0022149
http://id.nlm.nih.gov/mesh/M0383527
http://id.nlm.nih.gov/mesh/M0556121
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_61a59a5d966b00c6dad60bc09139ea63
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9305
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6d2eac63192f2d6e4b9b95cd225e2ba7
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7812
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173

Total number of triples: 50.